3D Medicines Inc. (HKG:1244)
Hong Kong · Delayed Price · Currency is HKD 3.800
+0.330 (9.51%)
At close: Mar 6, 2026
3D Medicines Market Cap
3D Medicines has a market cap or net worth of 932.46 million as of March 6, 2026. Its market cap has increased by 33.52% in one year.
Market Cap
932.46M
Enterprise Value
528.99M
Revenue
491.34M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.80
Market Cap Chart
Since December 15, 2022, 3D Medicines's market cap has decreased from 7.02B to 932.46M, a decrease of -86.72%. That is a compound annual growth rate of -46.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 932.46M | -28.71% |
| Dec 31, 2025 | 1.31B | 73.29% |
| Dec 31, 2024 | 754.73M | -56.44% |
| Dec 29, 2023 | 1.73B | -81.75% |
| Dec 30, 2022 | 9.49B | 35.14% |
| Dec 15, 2022 | 7.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Biostar Pharmaceuticals | 1.33B |
| Kintor Pharmaceutical | 1.26B |
| Shanghai Bio-heart Biological Technology | 1.13B |
| Wuhan YZY Biopharma | 1.10B |
| HighTide Therapeutics | 1.09B |
| Brii Biosciences | 988.50M |
| Sunho Biologics | 971.95M |
| Transcenta Holding | 877.29M |